Catheter ablation of atrial fibrillation in heart failure reduces mortality and hospitalization: The CASTLE-AF trial
1. Compared to medical therapy alone, catheter ablation of atrial fibrillation in patients with heart failure reduced the risk of...
Solanezumab does not change cognitive decline in mild Alzheimer’s disease
1. In patients with mild Alzheimer’s disease solanezumab, an antibody designed to facilitate clearance of amyloid-beta plaques, did not significantly...
No long-term neurodevelopmental effects of inhaled budesonide in preterm infants
1. Budesonide used for prevention of bronchopulmonary dysplasia in extremely preterm infants showed no difference in rate of neurodevelopmental disability...
Safety of MRI for patients with legacy cardiac devices
1. Patients with a legacy pacemaker or cardioverter-defibrillator were followed after undergoing medically indicated magnetic resonance imaging (MRI) examinations, and...
Reduced mortality with culprit-lesion-only percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock
1. In patients with acute myocardial infarction (MI) with cardiogenic shock and multivessel coronary disease, culprit-lesion-only percutaneous coronary intervention (PCI)...
Ablation of refractory ventricular tachycardia with a novel, noninvasive radiation technique
1. In this small case series of a novel treatment for ventricular tachycardia, patients receiving stereotactic body radiation therapy (SBRT)...
Fremanezumab reduces headache frequency in patients with chronic migraine
1. Patients with chronic migraine receiving fremanezumab had significantly fewer migraines and headaches than those receiving placebo after 12 weeks...
Screening program aids in safe ivermectin distribution in Loa loa endemic areas
1. The LoaScope, a mobile phone compatible device, accurately identified persons with high levels of circulating Loa loa (L. loa)...
